Corcept Therapeutics Incorporated
CORT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $3 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $3 | $2 | $2 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 39.9% | 20% | 9.8% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 98.4% | 98.7% | 98.7% | 98.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 20.5% | 22.5% | 28.3% | 35% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 20.7% | 22% | 25.2% | 30.7% |
| EPS Diluted | 1.23 | 0.94 | 0.87 | 0.89 |
| % Growth | 30.9% | 8% | -2.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |